Core Insights - U.S. online spending increased by 8.2% year-over-year in October, reaching $88.7 billion, with significant contributions from mobile purchases and Buy Now, Pay Later transactions [2][4] - Generative AI-driven traffic saw a remarkable surge of 1,200% year-over-year, leading to higher conversion rates and lower bounce rates among shoppers [3] - Health insurers are facing declines due to political statements suggesting a shift in funding away from traditional insurance companies [6] Online Spending Trends - Online spending in October was $88.7 billion, an 8.2% increase from the previous year [2] - Mobile purchases accounted for 51.4% of total online spending, up 11.6% year-over-year [4] - Buy Now, Pay Later transactions reached $7.1 billion, marking a 7.6% increase as consumers seek flexible budgeting options [4] Category Performance - Holiday décor sales surged by 130%, while home improvement categories like hand tools and power tools saw increases of 83% and 62%, respectively [5] - Appliance sales, particularly refrigerators and freezers, rose by 55%, benefiting companies like Whirlpool and Best Buy [5] - Other notable growth categories included e-readers (+81%), headphones and speakers (+52%), phone accessories (+51%), and video games (+41%) [5] Stock Market Movements - Health insurers such as Centene, Oscar Health, Elevance Health, and Molina Healthcare are experiencing stock declines due to negative political commentary [6] - Eli Lilly's stock rose after an upgrade from Leerink Partners, citing a favorable pricing deal for obesity drugs [7] - Monday.com shares fell after a disappointing fiscal Q4 revenue outlook, while Pagaya Technologies saw a stock surge following a strong Q3 performance [7] AI and Automotive Innovations - Tesla's CEO proposed a plan to compensate customers for allowing their parked vehicles to be used for AI workloads, potentially tapping into a vast network of vehicles [9] - The concept suggests a future with billions of AI-capable vehicles, significantly enhancing computational power available for AI tasks [9] Financial Market Insights - Analysts suggest shorting bonds of hyperscalers while avoiding major shorts in the broader AI sector, as hyperscaler cash flow is becoming insufficient for sustaining AI capital expenditures [10][12] - Over $120 billion in bonds have been issued recently, with widening credit spreads indicating potential challenges ahead for tech companies [12]

Core Insights - Wall Street is anticipating strong gains due to a bipartisan deal aimed at ending the federal government shutdown, which is currently the longest in U.S. history [1] - Futures for the S&P 500 rose by 0.9%, Dow Jones futures increased by 0.4%, and Nasdaq futures climbed by 1.5%, driven by optimism in the technology sector [1] - Health insurers are facing challenges as uncertainty regarding health care subsidies persists, impacting their market outlook [1] Market Reactions - The positive sentiment in the market is reflected in the futures, with S&P 500, Dow Jones, and Nasdaq all showing significant increases [1] - The technology sector is particularly strong, contributing to the rise in Nasdaq futures [1] Legislative Context - A test vote in the Senate has initiated procedural steps towards passing compromise legislation to fund the federal government, although final approval may take several days [1] - The ongoing negotiations lack a clear resolution regarding expiring health care subsidies, which are a point of contention for Democrats [1]

Core Insights - President Donald Trump's comments regarding federal health care funding have led to a decline in shares of health insurers, suggesting a potential shift in the Affordable Care Act (ACA) funding structure [1][4]. Group 1: Market Reaction - Centene (CNC), HCA Healthcare (HCA), and Molina Healthcare (MOH) experienced significant stock declines, with Centene down over 8%, Molina nearly 7%, and HCA dropping 5% [5]. - Other health insurers, including United Health Group (UNH) and Cigna Group (CI), also saw their shares fall following Trump's remarks [5]. Group 2: Policy Implications - Trump proposed that federal health care funds should be redirected to individuals rather than insurers, which could fundamentally alter the ACA marketplace [2]. - The Committee for a Responsible Federal Budget estimated that federal subsidies to insurance companies this year amount to $138 billion, a substantial increase from $53 billion in 2020 [2][4].

Core Insights - Palantir Technologies was the best-performing stock in the S&P 500, benefiting from the potential end of the U.S. government shutdown [2][7] Group 1: Market Performance - Major U.S. equities indexes rose, with the S&P 500 up close to 1% and the Nasdaq rising over 1%, driven by optimism regarding a spending plan to end the government shutdown [2][7] - Health insurance stocks, including Centene, declined after President Trump suggested that federal health insurance subsidies could be directed to individuals rather than insurers [3][7] Group 2: Company-Specific Developments - Micron Technology shares surged following positive comments from Mizuho Securities, indicating potential boosts from increased demand and pricing [3] - Eli Lilly's shares increased after announcing a partnership with Insilico Medicine to leverage artificial intelligence for drug discovery [3] - Metsera's shares fell after Novo Nordisk did not raise its bid for the company, allowing Pfizer to complete its $10 billion acquisition, which also caused Pfizer's shares to drop [4] - Ball's shares declined after the announcement of CEO Daniel Fisher's resignation, with Ronald Lewis set to replace him [4]

Investors with a lot of money to spend have taken a bearish stance on Molina Healthcare (NYSE:MOH).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MOH, it often means somebody knows something is about to happen.So how do we know what these investors just did? Today, Benzinga's options scanner sp ...

Skip to Main Content Skip to Search This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. Health Insurers Are Left Behind as Shutdown Fight Winds Down Updated Nov 10, 2025, 12:23 pm EST / Original Nov 10, 2025, 11:30 am EST Share Resize Reprints In this article SPX CNC OSCR HC ...

Core Insights - Oscar Health Inc (NYSE:OSCR) is experiencing a significant decline, down 15.9% to $14.98 amid a broader market rally, influenced by President Trump's remarks on redirecting funding to individuals [1] - The healthcare sector, including Oscar Health, is facing uncertainty due to potential government shutdown implications and the status of Obamacare subsidies [1] - Oscar Health's stock has seen a 35% decrease from its four-year high of $23.74 on October 7, although it remains up nearly 13% year-to-date [2] Company Performance - The current decline marks OSCR's worst single-session drop since July 2, with shares having finished higher only once in the last 10 trading days [2] - Short-term traders are exhibiting bearish sentiment, as indicated by the equity's Schaeffer's put/call open interest ratio (SOIR) of 1.16, which is in the 90th percentile of the past 12 months [2] Volatility and Strategy - A premium-selling strategy may be advisable moving forward, as OSCR's Schaeffer's Volatility Scorecard (SVS) is at 8 out of 100, indicating that the stock has consistently shown lower volatility than what its options pricing suggests [3]

Core Insights - Deep-pocketed investors have adopted a bearish approach towards Oscar Health, indicating potential significant market movements ahead [1] - The options activity shows a divided sentiment among heavyweight investors, with 33% bullish and 46% bearish [2] - The price target analysis suggests that major players are eyeing a price range from $10.0 to $40.0 for Oscar Health [3] Options Activity - A total of 30 extraordinary options activities were highlighted, with 7 puts totaling $3,241,865 and 23 calls amounting to $1,510,255 [2] - Significant options trades detected include various put and call options with notable trade prices and open interest [10] - The volume and open interest data for Oscar Health's options indicate liquidity and interest within the strike price range of $10.0 to $40.0 over the last 30 days [4][5] Company Overview - Oscar Health Inc is a health insurance company providing various insurance plans, including Medicare Advantage for eligible adults [11] - The current market status shows a price of $15.08, down 14.9%, with an upcoming earnings release expected in 85 days [16] - Professional analysts have set an average price target of $14.5, with differing ratings from Goldman Sachs and UBS [13][14]

I'm joined by Diane King Hall to take a look at some of the more movers. Uh this morning we're seeing the chips rallying. I was just having the conversation that as I was looking at the chips and the story popped up about Goulby and the chips dropped when he said there was uncertainty.Didn't know about rate cuts and chips went down today. Now maybe I don't know if rate cuts are back on the table if the government reopens. But also you're getting some positive news on chips.>> Yes. Uh certainly some momentum ...

Core Insights - Pelican Bay Capital Management (PBCM) reported a 7.8% return for its Concentrated Value Strategy in Q3 2025, outperforming the Russell 1000 Value Index which returned 5.3% during the same period [1]. - Year-to-date, PBCM's fund returned 11.2%, slightly below the index's 11.6% return [1]. Company Analysis - UnitedHealth Group Incorporated (NYSE:UNH) is highlighted as a significant holding in PBCM's portfolio, with a one-month return of -9.61% and a 52-week loss of 48.15% [2]. - As of November 7, 2025, UnitedHealth's stock closed at $324.21, with a market capitalization of $293.682 billion [2]. Industry Overview - The health insurance industry is experiencing significant pressure, with profitability in Medicaid and Medicare declining due to aggressive pricing from competitors and increased utilization of behavioral health services, GLP-1 drugs, and elective surgeries [3].